Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

WHO NewsJun 17, 2026
WHO issues comprehensive guidelines on filovirus disease, including Ebola and Marburg disease

Clinical Context

We think this has broad domain relevance to Fournier's Gangrene Severity Index (FGSI).

JAMAJun 16, 2026
Eating Less Protein May Improve Outcomes for Patients With Kidney Disease

Clinical Context

We think this has broad domain relevance to Fournier's Gangrene Severity Index (FGSI).

JAMAJun 16, 2026
A New Type 1 Diabetes Diagnosis Paradigm

Clinical Context

We think this has broad domain relevance to Fournier's Gangrene Severity Index (FGSI).

Fournier's Gangrene Severity Index

Fournier's Gangrene Severity Assessment

Vitals & Physiology

°C
bpm
bpm

Laboratory Values

mmol/L
mmol/L
mg/dL
mmol/L
%
10³/µL

Awaiting Values

Complete all 9 physiological and laboratory parameters to calculate the FGSI.

Guidelines & Evidence

Verified

Last Review: 2026

Overview & Clinical Context

Definition & Clinical Utility

Fournier’s gangrene is a rapidly progressive necrotizing fasciitis involving the perineum, genitalia, and perianal regions. The Fournier’s Gangrene Severity Index (FGSI) is a validated prognostic tool used at the time of admission to stratify disease severity and predict mortality risk. It enables clinicians to identify high-risk patients early, guide aggressiveness of management (e.g., ICU admission, early repeat debridement), and inform discussions regarding prognosis.

Why FGSI Matters in Practice

Provides objective mortality prediction at admission
Helps triage patients to ICU vs high-dependency care
Guides urgency and aggressiveness of surgical debridement
Useful for audit, research, and outcome benchmarking
Complements (but does not replace) clinical judgment

Pathophysiology of Fournier’s Gangrene

Fournier’s gangrene is typically polymicrobial, involving aerobic and anaerobic organisms that produce synergistic tissue destruction. Infection spreads along fascial planes (Colles’, Dartos’, Scarpa’s fascia), leading to microvascular thrombosis, ischemia, and rapid necrosis. Systemic toxicity results from sepsis, cytokine storm, and multiorgan dysfunction. FGSI captures this systemic derangement via physiological and laboratory abnormalities.

Last Comprehensive Review: 2026

Related Tools

APACHE II
SOFA Score
SIRS Criteria
Urology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.